Pediatric depression screening tool: Complete reference guide

A pediatric depression screening tool is a validated questionnaire that helps clinicians identify depression risk in children and adolescents aged 7 to 18. The PHQ-A is the standard choice for ages 12 to 17. The CDI-2 covers ages 7 to 17 and adds a parent-report version.

The US Preventive Services Task Force (USPSTF) recommends screening every adolescent aged 12 to 18 for major depressive disorder, a Grade B recommendation. It comes with one condition. The practice needs working systems for diagnosis, treatment, and follow-up before it starts screening.

The form below carries the age cutoffs, the PHQ-A score bands, and the follow-up each band calls for.

Key takeaways

The PHQ-A is validated for adolescents aged 12 to 17 and reports about 89.5% sensitivity and 77.5% specificity for depression.

The CDI-2 screens children aged 7 to 17 and comes in both self-report and parent-report versions.

USPSTF recommends screening every adolescent aged 12 to 18 (Grade B), while evidence for younger children is insufficient (Grade I).

Practice management software like Pabau sends the questionnaire before the visit, so the answers land on the client record before the child is seen.

What is a pediatric depression screening tool?

A pediatric depression screening tool is a brief questionnaire given during a clinical encounter to detect depressive symptoms in a young patient. Screening instruments are built for speed rather than diagnosis. Most take 5 to 10 minutes and flag the patients who need a fuller evaluation.

These instruments follow American Psychological Association (APA) depression assessment standards and are validated across diverse populations. A mental health EMR can administer the questionnaire, total the score, and flag an elevated result for clinician review.

• Brief (5 to 10 minutes), validated, and evidence-based
• Age-specific versions for different developmental stages
• Scoring cutoffs indicating no, mild, moderate, or severe symptoms
• Integrated into routine wellness and mental health visits

Recommended screening tools by age group

The table below summarizes the validated instruments used in primary care, pediatric, and mental health settings. Which one you reach for depends on the child’s age, who reports the symptoms, and the setting.

Read those age ranges against the guideline and the overlap becomes the decision. Three of the four instruments are validated well below 12, which is where the USPSTF recommendation begins.

PHQ-A: The standard adolescent depression screener

The PHQ-A (Patient Health Questionnaire-Adolescent) is the most widely used adolescent depression screener, validated for ages 12 to 17. It is a nine-item self-report questionnaire adapted from the adult PHQ-9. The Arizona Pediatric Psychiatry Access Line (APAL), a psychiatric consultation line for primary care providers, recommends it for pediatric screening.

In its validation study, the PHQ-A reported roughly 89.5% sensitivity and 77.5% specificity for major depressive disorder in adolescents. Those figures come from Johnson et al., 2002, in the Journal of Adolescent Health. A score of 11 or higher signals moderate-to-severe symptoms and warrants further evaluation.

Digital forms with built-in scoring logic cut manual calculation errors. An elevated total can be flagged for the clinician before the patient leaves the building.

The band sets the next action rather than the diagnosis. A total of 15 or above calls for an urgent mental health referral.

CDI-2: Screening younger children for depression

The Children’s Depression Inventory-2 (CDI-2) is validated for children aged 7 to 17. That is a wider developmental range than the PHQ-A offers. It comes in a 28-item full form and a 12-item short form. Separate self-report and parent-report versions are available.

The CDI-2 measures cognitive, affective, and behavioral symptoms of depression. It is used in pediatric primary care, school mental health programs, and specialty mental health practices. A therapy practice management system can hold the parent form and the child form under one record. The clinician then reads both at the point of care.

Where screening fits in the clinical workflow

Effective screening needs a settled workflow. Decide who is due, how the form reaches them, who scores it, and what follows a positive result.

The USPSTF is direct about that last point. Screening without systems for diagnosis and treatment spends staff time and can worry a family you cannot then help.

1. Identify the screening window. Annual wellness visits, sports physicals, and mental health intake appointments are the routine opportunities. An adolescent intake questionnaire is a natural place to attach the screener.
2. Administer the tool. The patient completes the questionnaire at check-in, which takes 5 to 10 minutes. Digital intake forms cut missing answers and can total the score for you.
3. Review the result. A score below threshold (PHQ-A under 11) needs routine follow-up. An elevated score triggers diagnostic assessment or referral.
4. Document and code. CPT code 96127 covers a brief emotional or behavioral assessment. Record the tool name, the score, and the follow-up plan.
5. Set the referral pathway. For a moderate-to-severe score, refer to psychiatry, psychology, or licensed counseling for a full evaluation.

The referral itself is where documentation usually stalls. A drafted letter that already carries the tool name, the score, and the date saves a second write-up.

Clinical considerations and referral guidance

A screening result is not a diagnosis. A positive screen indicates depression risk and calls for a full clinical evaluation by a qualified mental health professional. Recent stressors, medication side effects, and other medical conditions all need weighing before any treatment decision.

Refer every adolescent with a moderate-to-severe score (PHQ-A 11 or above) to mental health services. For a mild score alongside ongoing psychosocial stressors, consider psychoeducation or brief cognitive-behavioral strategies. Re-screen in four to six weeks and compare the two totals.

For children under 12 the USPSTF finds the evidence insufficient and does not recommend routine screening. A clinician may still screen in a high-risk context, such as known trauma, parental depression, or clear functional impairment. That decision rests on clinical judgment rather than on the recommendation.

Downloadable screening resources and scoring guides

The resources below are publicly available for clinical use, and most of the forms and scoring guides are free. The licensed instruments (CDI-2 and BDI-Y) have to be bought from the publisher. That is also where the normative data and clinician manuals come from.

• PHQ-A PDF and scoring guide: Free from the GLAD-PC toolkit, a REACH Institute and American Academy of Pediatrics (AAP) initiative published in Pediatrics
• CDI-2 manual and scoring sheet: Licensed through Pearson Assessments, with age-stratified norms and percentile rankings
• SMFQ scoring guide: Developed at Duke University, with free versions hosted on academic and clinical portals such as UCSF and the UW AIMS Center
• BDI-Y form and norms: Licensed from the publisher as part of the Beck Youth Inventories, where each subscale carries 20 items
• Clinical workflow templates: Many EHR and practice management platforms ship pre-built screening workflows with automated scoring

Storing these forms in one place is what keeps administration consistent. When the PHQ-A lives in the practice’s own form library, every clinician sends the same version. Every score then lands in the same field.

How Pabau handles screening forms and referral letters

In most practices the screener is a printed sheet handed over at check-in. The front desk chases the missing page and someone totals the score by hand. The number then reaches the clinical note late, or not at all.

Pabau, our all-in-one practice management system, sends the questionnaire to the parent or the adolescent before the appointment. The answers arrive on the client record, tied to that visit, so the clinician reads them before the child is in the room.

From there the same record carries the rest of the pathway. You write the treatment note against that visit and draft the referral letter from it. A recall reminder then books the four-to-six-week re-screen.

Every subscription includes every feature, so digital forms, treatment notes, and patient reminders are not a tier you upgrade into. The outcome is a screening program that runs the same way for every clinician in the practice.

Run pediatric screening from one patient record

Pabau sends the screening questionnaire before the visit and files the answers on the client record. Your team stops chasing paper forms and re-typing scores into the note.

Book a demo

Conclusion

Choosing the instrument is the easy part. Reach for the PHQ-A with an adolescent, and the CDI-2 when you also need the parent’s view.

Whether screening helps a patient is settled by the half of the workflow that follows the score. A practice with no referral route just produces flagged results and no treatment.

So build the pathway before you print the form. Decide where the score gets recorded, who reviews an elevated result, and which mental health service takes the referral. Book a demo to see how Pabau sends the screener ahead of the visit. The score, the note, and the referral letter then stay on one record.

Continue your research

Need the adult version of the Beck inventory? Beck Depression Inventory covers the scoring bands and the licensing route for the full BDI form.

Screening the same adolescent for substance use? CRAFFT screening tool template gives you the questionnaire and its scoring cutoffs for adolescent substance use.

Assessing attention symptoms alongside mood? Vanderbilt ADHD Rating Scale scoring guide covers comorbidity in children who present with both mood and attention concerns.

Frequently asked questions